Softwr

Research · head to head

Form Bio vs TetraScience

Form Bio logo

Form Bio

Research

Computational platform for cell and gene therapy design and manufacturability

From
On request
Rated
-
Full reviewWebsite
TetraScience logo

TetraScience

Research

Scientific data cloud that harmonises instrument output across the lab estate

From
On request
Rated
-
Full reviewWebsite

The short version

  • Each has a real cost: Form Bio the company has pivoted twice since spinning out of Colossal Biosciences in 2022, from general computational life sciences to cell and gene therapy and then to AAV manufacturability, so any evaluation more than a year old describes a product that is no longer the commercial focus.; TetraScience pricing is scoped on connected instruments and data engineering effort rather than a published unit, so the cost of adding a new laboratory or an acquired site is impossible to forecast without going back to the vendor.
  • They diverge on capability: Form Bio covers FormManufacturing, TetraScience covers Instrument connectors.
  • Prices and features above were last checked on 31 August 2026.

Where they differ

Only the attributes on which Form Bio and TetraScience actually diverge.

Attributes where Form Bio and TetraScience differ
AttributeForm BioTetraScience
PlatformsWeb, CloudWeb, Cloud, API

Identical on both: starting price (On request), pricing model (quote), free tier (No), user rating (Not yet rated), category (Research).

What each one covers

Drawn from each product's published feature list. An absence here means we hold no record of it - not that the product lacks it.

Only in Form Bio

  • FormManufacturing
  • Payload design optimisation
  • Genome integrity analysis
  • Manufacturability prediction
  • In silico workflows
  • Scale-up monitoring
  • Cell and gene therapy focus
  • Collaboration

Only in TetraScience

  • Instrument connectors
  • Tetra Data harmonisation
  • Cloud-native data platform
  • GxP package
  • Scientific applications
  • Data provenance
  • Open access
  • AWS Marketplace availability

What people use each for

The jobs each tool is most often brought in to do.

Form Bio

  • A gene therapy developer discovering manufacturability problems with an AAV construct late in process development and wanting to move that analysis earliernot TetraScience
  • A biotech comparing several candidate payload designs in silico before committing to expensive production runsnot TetraScience
  • A CDMO characterising what a client construct actually produces against what was specifiednot TetraScience
  • A programme team needing genome integrity evidence to support regulatory conversations about product consistencynot TetraScience

TetraScience

  • A pharmaceutical company trying to make twenty years of chromatography data usable for modelling rather than trapped on instrument workstationsnot Form Bio
  • A biotech building machine learning models on assay data that currently requires manual export from every instrumentnot Form Bio
  • A quality control laboratory needing instrument data captured with provenance and audit trail for regulated usenot Form Bio
  • A company consolidating data from acquired sites where each site runs a different instrument vendor and informatics stacknot Form Bio

Where each one falls short

Documented limitations, not opinions. Every one is a constraint you would hit in normal use.

Form Bio

  • The company has pivoted twice since spinning out of Colossal Biosciences in 2022, from general computational life sciences to cell and gene therapy and then to AAV manufacturability, so any evaluation more than a year old describes a product that is no longer the commercial focus.
  • The current offering launched AAV-focused, so developers working in lentiviral, mRNA or cell therapy modalities are outside the scope the platform was built and validated for.
  • No pricing is published and engagements are scoped per programme, which makes it impossible to size the commitment before entering a sales process.
  • This is a young venture-funded company whose analyses feed regulatory-facing decisions, so continuity of the vendor over a multi-year development programme is a genuine diligence question rather than a formality.
  • Predictive manufacturability models need real production data to be trustworthy, and the value depends on how much of that a young vendor has accumulated, which is difficult for a buyer to verify independently.

TetraScience

  • Pricing is scoped on connected instruments and data engineering effort rather than a published unit, so the cost of adding a new laboratory or an acquired site is impossible to forecast without going back to the vendor.
  • Value depends entirely on connector coverage for your actual instrument estate; an instrument type without an existing productised connector becomes a services engagement with its own timeline and cost.
  • The GxP package is a separate annual subscription rather than an included capability, so a company that starts in research and later needs regulated use faces an additional commercial line and a validation exercise.
  • It is infrastructure with no end-user application of its own, so the business case rests on downstream analytics and AI work that has to be resourced and delivered separately before anyone sees a benefit.
  • Deployment is a multi-year programme touching instruments, networks, validated systems and site IT, and organisations consistently underestimate the internal effort required from people who also have day jobs running the laboratory.

Pricing, plan by plan

Form Bio

On request
  • FormManufacturing$undefined/year
    • Pricing only through a sales process
    • Scoped per therapeutic programme rather than per seat
    • AAV-focused offering at launch

TetraScience

On request
  • Tetra Scientific Data Cloud$undefined/year
    • Priced on number of instruments connected and scope of data engineering
    • Contract entitles a specified quantity of use for its duration
    • Multi-year enterprise agreements are the norm
  • Tetra GxP package$undefined/year
    • Separate annual subscription executed within the licence agreement
    • Audit trail, data provenance, control matrices and software hazard analysis
    • Disaster recovery provisions

Which should you pick?

Choose Form Bio if

  • You need formmanufacturing.
  • You work on Web, Cloud.
  • You also want payload design optimisation.
Form Bio review

Choose TetraScience if

  • You need instrument connectors.
  • You work on Web, Cloud, API.
  • You also want tetra data harmonisation.
TetraScience review

Questions people ask

Is Form Bio or TetraScience better?
Neither clearly leads. Form Bio starts at On request and TetraScience at On request, and user ratings are close enough to be indistinguishable. Choose on capability and platform support.
Which is cheaper, Form Bio or TetraScience?
Form Bio starts at On request and TetraScience at On request.
Does Form Bio or TetraScience run on more platforms?
Form Bio runs on Web, Cloud. TetraScience runs on Web, Cloud, API.
What is Form Bio best used for?
Form Bio is most often used for a gene therapy developer discovering manufacturability problems with an aav construct late in process development and wanting to move that analysis earlier, a biotech comparing several candidate payload designs in silico before committing to expensive production runs, a cdmo characterising what a client construct actually produces against what was specified, a programme team needing genome integrity evidence to support regulatory conversations about product consistency. Of those, a gene therapy developer discovering manufacturability problems with an aav construct late in process development and wanting to move that analysis earlier and a biotech comparing several candidate payload designs in silico before committing to expensive production runs are not what TetraScience is typically brought in for.
What can Form Bio do that TetraScience cannot?
Form Bio covers FormManufacturing, Payload design optimisation, Genome integrity analysis, Manufacturability prediction. TetraScience covers Instrument connectors, Tetra Data harmonisation, Cloud-native data platform, GxP package.

Answered from the vendors’ own pages

Form Bio: What does Form Bio sell now?

FormManufacturing, launched in 2026, an AAV-focused platform for predicting, optimising and monitoring manufacturability of genetic medicines from construct design through scale-up.

TetraScience: What is the pricing unit?

Connected instruments and the scope of data engineering, over a fixed contract term. There is no published per-seat or per-gigabyte rate.

Form Bio: Is it still a general bioinformatics platform?

No. It has narrowed from broad computational life sciences tooling to cell and gene therapy, and within that to AAV.

TetraScience: Does it replace my ELN or LIMS?

No. It sits underneath them, harmonising instrument data and making it available to whatever applications you already run.

Form Bio: Where did the company come from?

It spun out of Colossal Biosciences in 2022.

TetraScience: Is it usable in a GxP environment?

Yes, with the separately subscribed Tetra GxP package. It reduces validation effort substantially but does not eliminate your validation obligation.

Form Bio: Is pricing published?

No. Engagements are scoped per programme through a sales process.

TetraScience: Can I get the harmonised data out?

Yes. Tetra Data is designed to be accessible to your own analytics tools rather than confined to the platform.

Share

Related pages

More on Form Bio

More on TetraScience

Keep looking

Other head to heads